Cleared Traditional

K033405 - LONGFEI LFY-I-5 OXYGEN CONCENTRATOR

K033405 is an FDA 510(k) clearance for LONGFEI LFY-I-5 OXYGEN CONCENTRATOR, manufactured by Zhejiang Longfei Industrial Co., Ltd.. The device is a Class 2 Anesthesiology device with product code CAW cleared through the Traditional 510(k) pathway after a 725-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 2005
Decision
725d
Days
Class 2
Risk

K033405 is an FDA 510(k) clearance for the LONGFEI LFY-I-5 OXYGEN CONCENTRATOR. Classified as Generator, Oxygen, Portable within the CAW classification (a category for home-use oxygen therapy and respiratory devices), Class II - Special Controls.

Submitted by Zhejiang Longfei Industrial Co., Ltd. (Shanghai, CN). The FDA issued a Cleared decision on October 18, 2005 after a review of 725 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Anesthesiology FDA review panel, regulated under 21 CFR 868.5440 - the FDA anesthesiology and respiratory device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: High-complexity regulatory submission. Elevated predicate reliance profile. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Anesthesiology submissions.

View all Zhejiang Longfei Industrial Co., Ltd. devices

FDA 510(k) Submission Details - K033405

510(k) Number K033405 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 24, 2003
Decision Date October 18, 2005
Days to Decision 725 days
Submission Type Traditional
Review Panel Anesthesiology (AN)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
585d slower than avg
Panel avg: 140d · This submission: 725d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

CAW Device Classification - Class 2, Special Controls

Product Code CAW Generator, Oxygen, Portable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 868.5440
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Anesthesiology devices follow this clearance model.

Regulatory Peers - CAW Generator, Oxygen, Portable

All 121
Devices cleared under the same product code (CAW) and FDA review panel - the closest regulatory comparables to K033405.
L4 OXYGEN CONCENTRATOR
K061261 · Respironics, Inc. · Jun 2006
MERITS HEALTH PRODUCTS OXYGEN CONCENTRATORS
K053230 · Merits Health Products Co., Ltd. · May 2006
MERITS HEALTH PRODUCTS OXYGEN CONCENTRATORS
K053229 · Merits Health Products Co., Ltd. · Mar 2006
MERITS HEALTH PRODUCTS OXYGEN CONCENTRATOR
K050430 · Merits Health Products Co., Ltd. · Aug 2005
MILLENNIUM M10 OXYGEN CONCENTRATOR, MODEL M10600
K043006 · Respironics, Inc. · Feb 2005
VENTURE HOMEFILL II WITH OXYGEN CONSERVER
K021685 · Invacare Corp. · Jul 2002